Knowledge (XXG)

Brainsway

Source 📝

513: 475:
Bersani, FS; Minichino, A; Enticott, PG; Mazzarini, L; Khan, N; Antonacci, G; Raccah, RN; Salviati, M; Delle Chiaie, R; Bersani, G; Fitzgerald, PB; Biondi, M (January 2013). "Deep transcranial magnetic stimulation as a treatment for psychiatric disorders: a comprehensive review".
255:
BrainsWay was founded in 2003 in Delaware by Uzi Sofer and Avner Hagai, together with David Zacut and they set up a subsidiary in Jerusalem, and obtained an exclusive license from the NIH for the patent it filed on the H coil. By 2006 the company had conducted animal studies at
249:(TMS) provide a shallow magnetic field that affects neurons mostly on the surface of the brain, delivered with coil shaped like the number eight. The H coil provided magnetic fields deeper in the brain, and devices using them provide what is called "deep TMS". 297:
to market its deep TMS device in the United States and in Canada as a treatment for treatment-resistant major depressive disorder. Evidence to support this use is tentative as of 2013 no high quality evidence is available.
927: 845:
Roth, Yiftach; Zangen, Abraham (2012). "Basic Principles and Methodological Aspects of Transcranial Magnetic Stimulation". In Miniussi, Carlo; Paulus, Walter; Rossini, Paolo M. (eds.).
301:
In August 2020, BrainsWay received FDA clearance for its deep TMS device for use in smoking addiction. The device has also previously been cleared by the FDA using an H1-coil for
912: 52: 907: 917: 877: 581: 323: 741: 659: 773: 603: 882: 932: 714: 937: 922: 626: 858: 547: 238: 306: 607: 290: 246: 214: 902: 333: 237:
technology used by BrainsWay's devices, called the "H coil", emerged from research done in the late 1990s and early 2000s at the
24: 450: 252:
The H-coil was patented by the NIH in 2002, and the procedure whereby the H-coil was applied to TMS became known as Deep TMS.
286:. In 2010 BrainsWay announced plans to list shares of the company's stock on the Nasdaq exchange but withdrew them in June. 257: 222: 318: 102: 528:"Chapter 10: Repetitive Transcranial Magnetic Stimulation in Depression: Protocols, Mechanisms, and New Developments" 691: 572:"Scientists in Israel are reaching deeper into the minds of the clinically depressed to try to lift their spirits" 751: 669: 302: 218: 124: 897: 892: 887: 213:) is an international company that is engaged in the development of a medical device that uses H-coil for deep 353:"REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934" 571: 272: 268: 151: 48: 512: 611: 389: 636: 352: 261: 225:, and smoking addiction. The company was founded in 2003 and has offices in the US and Jerusalem. 833: 746: 664: 631: 501: 277: 70: 854: 825: 543: 527: 493: 405: 815: 806: 485: 397: 206: 393: 719: 539: 242: 144: 34: 401: 871: 294: 234: 60: 42: 837: 505: 245:, Roy A. Wise, Mark Hallett, Pedro C. Miranda and Yiftach Roth. Most coils used in 424: 328: 820: 801: 489: 177: 850: 604:"Magnetic Stimulation Shows Promise as the New Wave for Treating Depression" 23: 829: 497: 409: 109: 576: 535: 56: 715:"Brainsway Rises as U.S. Allows Depression Device: Tel Aviv Mover" 774:"FDA clears first brain stimulation device for smoking cessation" 451:"Israel's BrainsWay stimulates a magnetic remedy for depression" 532:
Neurofeedback and Neuromodulation Techniques and Applications
526:
Spronk, Desirée; Arns, Martijn; Fitzgerald, Paul B. (2011).
380:
George, Mark S. (September 2003). "Stimulating the Brain".
260:
and had run its first clinical trial assessing safety, at
289:
In January 2013, BrainsWay received clearance from the
191: 742:"Health Canada approves Brainsway depression therapy" 186: 176: 168: 160: 135: 119: 94: 76: 66: 40: 30: 928:Companies listed on the Tel Aviv Stock Exchange 802:"Transcranial Magnetic Stimulation: A Primer" 8: 530:. In Coben, Robert; Evans, James R. (eds.). 16: 913:Manufacturing companies established in 2003 444: 442: 440: 438: 217:(Deep TMS) as a non-invasive treatment for 324:List of Israeli inventions and discoveries 22: 15: 908:Health care companies established in 2003 819: 627:"Brainsway IPO four times oversubscribed" 470: 468: 918:Technology companies established in 2003 658:Habib-Valdhorn, Shiri (8 August 2010). 344: 878:Medical technology companies of Israel 449:Blackburn, Nicky (19 February 2006). 7: 660:"Brainsway looks to Nasdaq offering" 584:from the original on 3 December 2013 267:In early 2007 BrainsWay executed an 694:. Renaissance Capital. 14 June 2011 570:Heller, Corinne (7 December 2006). 210: 239:U.S. National Institutes of Health 14: 750:. 15 January 2013. Archived from 608:NIH Office of Technology Transfer 402:10.1038/scientificamerican0903-66 291:U.S. Food and Drug Administration 247:transcranial magnetic stimulation 215:transcranial magnetic stimulation 713:Wainer, Davic (9 January 2013). 625:Weinreb, Gali (2 January 2007). 511: 423:Rapp, David (17 February 2005). 334:Science and technology in Israel 883:Physical psychiatric treatments 933:Companies listed on the Nasdaq 847:Transcranial Brain Stimulation 800:Hallett, Mark (19 July 2007). 610:. 24 July 2007. Archived from 1: 938:2007 initial public offerings 923:2003 establishments in Israel 258:Weizmann Institute of Science 821:10.1016/j.neuron.2007.06.026 490:10.1016/j.eurpsy.2012.02.006 319:List of companies of Israel 82:; 21 years ago 954: 692:"Brainsway withdraws IPO" 303:major depressive disorder 125:Burlington, Massachusetts 21: 172:Brain Disorder treatment 903:Treatment of depression 273:Tel Aviv Stock Exchange 269:initial public offering 542:. pp. 278–279. 360:mayafiles.tase.co.il 282:for a market cap of 754:on 18 February 2013 672:on 17 February 2013 478:European Psychiatry 394:2003SciAm.289c..66G 382:Scientific American 262:Tel Aviv University 18: 639:on 21 January 2010 71:Medical technology 860:978-1-43-987570-4 614:on 30 March 2013. 549:978-0-12-382235-2 425:"Field of Dreams" 200: 199: 945: 864: 841: 823: 788: 787: 785: 784: 778:www.bioworld.com 770: 764: 763: 761: 759: 738: 732: 731: 729: 727: 710: 704: 703: 701: 699: 688: 682: 681: 679: 677: 668:. Archived from 655: 649: 648: 646: 644: 635:. Archived from 622: 616: 615: 600: 594: 593: 591: 589: 567: 561: 560: 558: 556: 523: 517: 516: 515: 509: 472: 463: 462: 460: 458: 446: 433: 432: 420: 414: 413: 377: 371: 370: 368: 367: 357: 349: 305:and H7-coil for 285: 281: 212: 196: 193: 90: 88: 83: 26: 19: 953: 952: 948: 947: 946: 944: 943: 942: 898:Neurotechnology 893:Neuropsychology 888:Neurophysiology 868: 867: 861: 844: 799: 796: 794:Further reading 791: 782: 780: 772: 771: 767: 757: 755: 740: 739: 735: 725: 723: 712: 711: 707: 697: 695: 690: 689: 685: 675: 673: 657: 656: 652: 642: 640: 624: 623: 619: 602: 601: 597: 587: 585: 569: 568: 564: 554: 552: 550: 525: 524: 520: 510: 474: 473: 466: 456: 454: 448: 447: 436: 422: 421: 417: 379: 378: 374: 365: 363: 362:. December 2023 355: 351: 350: 346: 342: 315: 283: 276: 231: 190: 164:Deep TMS System 156: 138: 131: 127: 115: 86: 84: 81: 55: 45: 12: 11: 5: 951: 949: 941: 940: 935: 930: 925: 920: 915: 910: 905: 900: 895: 890: 885: 880: 870: 869: 866: 865: 859: 842: 814:(2): 187–199. 795: 792: 790: 789: 765: 733: 705: 683: 650: 617: 595: 562: 548: 540:Academic Press 518: 464: 434: 415: 372: 343: 341: 338: 337: 336: 331: 326: 321: 314: 311: 243:Abraham Zangen 230: 227: 203:BrainsWay Ltd. 198: 197: 188: 184: 183: 182:Brainsway Inc. 180: 174: 173: 170: 166: 165: 162: 158: 157: 155: 154: 148: 145:Abraham Zangen 141: 139: 136: 133: 132: 129: 123: 121: 117: 116: 114: 113: 106: 98: 96: 92: 91: 78: 74: 73: 68: 64: 63: 46: 41: 38: 37: 32: 28: 27: 17:BrainsWay Ltd. 13: 10: 9: 6: 4: 3: 2: 950: 939: 936: 934: 931: 929: 926: 924: 921: 919: 916: 914: 911: 909: 906: 904: 901: 899: 896: 894: 891: 889: 886: 884: 881: 879: 876: 875: 873: 862: 856: 852: 848: 843: 839: 835: 831: 827: 822: 817: 813: 809: 808: 803: 798: 797: 793: 779: 775: 769: 766: 753: 749: 748: 743: 737: 734: 722: 721: 716: 709: 706: 693: 687: 684: 671: 667: 666: 661: 654: 651: 638: 634: 633: 628: 621: 618: 613: 609: 605: 599: 596: 583: 579: 578: 573: 566: 563: 551: 545: 541: 537: 533: 529: 522: 519: 514: 507: 503: 499: 495: 491: 487: 483: 479: 471: 469: 465: 452: 445: 443: 441: 439: 435: 430: 426: 419: 416: 411: 407: 403: 399: 395: 391: 387: 383: 376: 373: 361: 354: 348: 345: 339: 335: 332: 330: 327: 325: 322: 320: 317: 316: 312: 310: 308: 304: 299: 296: 295:Health Canada 292: 287: 279: 274: 270: 265: 263: 259: 253: 250: 248: 244: 240: 236: 235:magnetic coil 228: 226: 224: 220: 216: 208: 204: 195: 189: 185: 181: 179: 175: 171: 167: 163: 159: 153: 149: 146: 143: 142: 140: 134: 130:United States 126: 122: 118: 111: 108:David Zacut ( 107: 104: 101:Avner Hagai ( 100: 99: 97: 93: 79: 75: 72: 69: 65: 62: 58: 54: 50: 47: 44: 39: 36: 33: 29: 25: 20: 846: 811: 805: 781:. Retrieved 777: 768: 756:. Retrieved 752:the original 745: 736: 724:. Retrieved 718: 708: 696:. Retrieved 686: 674:. Retrieved 670:the original 663: 653: 641:. Retrieved 637:the original 630: 620: 612:the original 598: 586:. Retrieved 575: 565: 553:. Retrieved 531: 521: 481: 477: 455:. Retrieved 428: 418: 388:(3): 66–73. 385: 381: 375: 364:. Retrieved 359: 347: 329:Neuroscience 300: 288: 284:₪110 million 266: 254: 251: 232: 202: 201: 178:Subsidiaries 150:Hadar Levy ( 147:Yiftach Roth 120:Headquarters 31:Company type 484:(1): 30–9. 453:. Israel21c 872:Categories 783:2020-08-27 758:26 January 726:11 January 698:11 January 676:11 January 643:11 January 588:11 January 555:11 January 457:11 January 366:2024-04-25 340:References 280:33 million 275:, raising 219:depression 211:בריינסוויי 137:Key people 851:CRC Press 720:Bloomberg 293:and from 241:(NIH) by 192:brainsway 103:president 43:Traded as 838:11768337 830:17640522 582:Archived 506:29053871 498:22559998 410:12951829 313:See also 169:Services 161:Products 110:chairman 67:Industry 577:Reuters 429:Haaretz 390:Bibcode 271:on the 229:History 187:Website 95:Founder 85: ( 77:Founded 59::  51::  857:  836:  828:  807:Neuron 747:Globes 665:Globes 632:Globes 546:  536:London 504:  496:  408:  207:Hebrew 57:Nasdaq 35:Public 834:S2CID 502:S2CID 356:(PDF) 855:ISBN 826:PMID 760:2013 728:2013 700:2013 678:2013 645:2013 590:2013 557:2013 544:ISBN 494:PMID 459:2013 406:PMID 233:The 194:.com 87:2003 80:2003 61:BWAY 53:BRIN 49:TASE 816:doi 486:doi 398:doi 386:289 307:OCD 223:OCD 152:CEO 874:: 853:. 849:. 832:. 824:. 812:55 810:. 804:. 776:. 744:. 717:. 662:. 629:. 606:. 580:. 574:. 538:: 534:. 500:. 492:. 482:28 480:. 467:^ 437:^ 427:. 404:. 396:. 384:. 358:. 309:. 264:. 221:, 209:: 128:, 863:. 840:. 818:: 786:. 762:. 730:. 702:. 680:. 647:. 592:. 559:. 508:. 488:: 461:. 431:. 412:. 400:: 392:: 369:. 278:₪ 205:( 112:) 105:) 89:)

Index


Public
Traded as
TASE
BRIN
Nasdaq
BWAY
Medical technology
president
chairman
Burlington, Massachusetts
Abraham Zangen
CEO
Subsidiaries
brainsway.com
Hebrew
transcranial magnetic stimulation
depression
OCD
magnetic coil
U.S. National Institutes of Health
Abraham Zangen
transcranial magnetic stimulation
Weizmann Institute of Science
Tel Aviv University
initial public offering
Tel Aviv Stock Exchange

U.S. Food and Drug Administration
Health Canada

Text is available under the Creative Commons Attribution-ShareAlike License. Additional terms may apply.